Cargando...

Comparison of Power Between Randomized Discontinuation Design and Upfront Randomization Design on Progression-Free Survival

PURPOSE: Enrichment based on molecular characteristics has emerged as an important inclusion criterion in phase II trials of targeted anticancer agents. In this study, we evaluate a well-described method of population enrichment by tumor growth characteristics in the early development stage of targe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fu, Pingfu, Dowlati, Afshin, Schluchter, Mark
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2734425/
https://ncbi.nlm.nih.gov/pubmed/19636018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.6709
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!